These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 32271791)

  • 1. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients.
    Wu ZH; Zhou T; Sun HY
    Medicine (Baltimore); 2020 Jun; 99(24):e20682. PubMed ID: 32541515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
    Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
    World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
    Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
    J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
    Liu J; Li X; Yang S; Mou J; Lu H
    Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of gene expression and DNA methylation for human nasopharyngeal carcinoma.
    Li H; Wang FL; Shan LP; An J; Liu ML; Li W; Zhang JE; Wu PP
    Eur Arch Otorhinolaryngol; 2019 Sep; 276(9):2565-2576. PubMed ID: 31240455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Fu Z
    Arch Oral Biol; 2019 Oct; 106():104478. PubMed ID: 31319350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of aberrantly methylated differentially expressed genes and validation of CDC6 in melanoma.
    Liao L; Han W; Shen Y; Shen G
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):362. PubMed ID: 39052109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
    Zhang JZ; Wu ZH; Cheng Q
    Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying key genes and small molecule compounds for nasopharyngeal carcinoma by various bioinformatic analysis.
    Fang L; Shi L; Wang W; Chen Q; Rao X
    Medicine (Baltimore); 2021 Sep; 100(37):e27257. PubMed ID: 34664875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation.
    Wen JY; Qin LT; Chen G; Huang HQ; Shen MJ; Pang JS; Tang YX; Lu W; Wang RS; Luo JY
    Dis Markers; 2022; 2022():7962220. PubMed ID: 35251377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Programmed Cell Death-Related Biomarkers and Disease Therapy Strategy in Nasopharyngeal Carcinoma Using Transcriptomics.
    Yan J; Wu L; Zheng M; Pan F
    Front Biosci (Landmark Ed); 2024 Jun; 29(7):240. PubMed ID: 39082346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Song Y; Feng T; Cao W; Yu H; Zhang Z
    Comput Intell Neurosci; 2022; 2022():9022700. PubMed ID: 35712071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.